Early stage pharmaceutical company Alitair Pharmaceuticals will offer benzonatate formulation with Rx-to-OTC switch potential.
Subscribe to our email newsletter
Alitair provided additional details regarding its ‘398 patent specific to formulations of benzonatate.
At present, benzonatate is the only non-narcotic prescription cough product available, according to the company
The tablet eliminates the potential for numbing, thus reducing or eliminating the danger of choking.